NCT04920786View on ClinicalTrials.gov

Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

May 3, 2022

Study Completion Date

May 3, 2022

Conditions

Alzheimer Disease

Interventions

DRUG

TB006

TB006

OTHER

Sterile saline (Placebo)

Sterile saline

Trial Locations (1)

90806

Collaborative Neuroscience Research, LLC (CNS), Long Beach

All Listed Sponsors

lead

TrueBinding, Inc.

INDUSTRY